143

Neurology
Focuses on brain health.
Sub Categories on Neurology
Latest Articles
Finding epilepsy hotspots before surgery: A faster, non-invasive approach

Finding epilepsy hotspots before surgery: A faster, non-invasive approach

by Nancy Fliesler,Children's Hospital BostonCredit: Pixabay/CC0 Public DomainNeurosurgery for patients with drug-resistant epilepsy requires locating the precise brain areas that are generat

Finding epilepsy hotspots before surgery: A faster, non-invasive approach

by Nancy Fliesler,Children's Hospital BostonCredit: Pixabay/CC0 Public DomainNeurosurgery for patients with drug-resistant epilepsy requires locating the precise brain areas that are generat
Surgery-free brain stimulation could provide new treatment for dementia

Surgery-free brain stimulation could provide new treatment for dementia

by Ryan O'Hare,Imperial College LondonTemporal interference (TI) is non-invasive and delivers electrical stimulation through electrodes placed on the participant's head. Credit: Imperial

Surgery-free brain stimulation could provide new treatment for dementia

by Ryan O'Hare,Imperial College LondonTemporal interference (TI) is non-invasive and delivers electrical stimulation through electrodes placed on the participant's head. Credit: Imperial
How heavy alcohol consumption increases brain inflammation

How heavy alcohol consumption increases brain inflammation

by The Scripps Research InstituteResearchers discovered higher than usual levels of the immune signaling molecule interleukin 1β (green) in neurons (outlined in red) from the brains of alcohol-de

How heavy alcohol consumption increases brain inflammation

by The Scripps Research InstituteResearchers discovered higher than usual levels of the immune signaling molecule interleukin 1β (green) in neurons (outlined in red) from the brains of alcohol-de
How the brain wakes us from daydreams

How the brain wakes us from daydreams

by Children's Hospital BostonDistinct behavioral correlates of DSs. Credit:Nature(2024). DOI: 10.1038/s41586-024-07192-8When we daydream, we must be able to snap back to attention

How the brain wakes us from daydreams

by Children's Hospital BostonDistinct behavioral correlates of DSs. Credit:Nature(2024). DOI: 10.1038/s41586-024-07192-8When we daydream, we must be able to snap back to attention
Black patients face delays in Alzheimer's diagnosis, research finds

Black patients face delays in Alzheimer's diagnosis, research finds

by Radiological Society of North AmericaBrain MRI images. Credit: RSNA/Joshua Wibecan, M.D.Black patients underwent medical imaging for cognitive impairment years later than white and Hispanic pa

Black patients face delays in Alzheimer's diagnosis, research finds

by Radiological Society of North AmericaBrain MRI images. Credit: RSNA/Joshua Wibecan, M.D.Black patients underwent medical imaging for cognitive impairment years later than white and Hispanic pa
Stalked by the fear that dementia is stalking you

Stalked by the fear that dementia is stalking you

by Judith GrahamCredit: CC0 Public DomainDo I know I'm at risk for developing dementia? You bet.My father died of Alzheimer's disease at age 72; my sister was felled byfrontotemporal dem

Stalked by the fear that dementia is stalking you

by Judith GrahamCredit: CC0 Public DomainDo I know I'm at risk for developing dementia? You bet.My father died of Alzheimer's disease at age 72; my sister was felled byfrontotemporal dem
Alzheimer's: Nicotinic receptors as a new therapeutic target

Alzheimer's: Nicotinic receptors as a new therapeutic target

by Institut PasteurRepresentation of space in the nicotinic receptor. Credit: Institut PasteurSeveral scientific studies have indicated that nicotine may be beneficial for memory function. Scientists

Alzheimer's: Nicotinic receptors as a new therapeutic target

by Institut PasteurRepresentation of space in the nicotinic receptor. Credit: Institut PasteurSeveral scientific studies have indicated that nicotine may be beneficial for memory function. Scientists
A therapeutic target for Alzheimer's disease discovered

A therapeutic target for Alzheimer's disease discovered

by Laval UniversityFRET ratio is independent of laser intensity, and imaging depth was comparable between NonTg and 5xFAD mice. (A) Confocal image of the AAV2/9.CaMKIIa.SuperClomeleon (SCLM) infe

A therapeutic target for Alzheimer's disease discovered

by Laval UniversityFRET ratio is independent of laser intensity, and imaging depth was comparable between NonTg and 5xFAD mice. (A) Confocal image of the AAV2/9.CaMKIIa.SuperClomeleon (SCLM) infe
New memory drug moves into Phase 1 clinical study

New memory drug moves into Phase 1 clinical study

by National Institutes of HealthAn experimental drug that may improve memory is now being tested in a Phase 1 safety trial. The compound, BPN14770, was developed by Tetra Discovery Partners, with

New memory drug moves into Phase 1 clinical study

by National Institutes of HealthAn experimental drug that may improve memory is now being tested in a Phase 1 safety trial. The compound, BPN14770, was developed by Tetra Discovery Partners, with
Attention and memory deficits persist for months after recovery from mild COVID

Attention and memory deficits persist for months after recovery from mild COVID

by University of OxfordGraphical abstract. Credit: DOI: 10.1093/braincomms/fcab295Researchers from Oxford's Department of Experimental Psychology and Nuffield Department of Clinical Neuroscie

Attention and memory deficits persist for months after recovery from mild COVID

by University of OxfordGraphical abstract. Credit: DOI: 10.1093/braincomms/fcab295Researchers from Oxford's Department of Experimental Psychology and Nuffield Department of Clinical Neuroscie
Alzheimer's drug donanemab has been hailed as a turning point. But what does it mean for people with the disease?

Alzheimer's drug donanemab has been hailed as a turning point. But what does it mean for people with the disease?

by Steve Macfarlane,The ConversationCredit: AI-generated imageTrial results of a new drug to treat Alzheimer's disease, donanemab, shows it canslow cognitive declineby 35%. The d

Alzheimer's drug donanemab has been hailed as a turning point. But what does it mean for people with the disease?

by Steve Macfarlane,The ConversationCredit: AI-generated imageTrial results of a new drug to treat Alzheimer's disease, donanemab, shows it canslow cognitive declineby 35%. The d